Aseptically Manipulated or Terminally Sterile Medicinal Products

Description

The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags and pre-filled syringes. This procurement is being managed by the Peninsula Purchasing and Supply Alliance (hereafter referred to as the PPSA) on behalf of the Royal Devon University Healthcare NHS Foundation Trust (hereafter referred to as the Organisation) acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust. Lot 1: Aseptically prepared products Supply of Cyclophosphamide, Doxorubicin & Pembrolizumab compounded ready-to-use batch and patient-specific products. Additional information: The invitation to tender (ITT) documents and additional information is available from CTM e-procurement portal at https://uk.eu-supply.com Tenders or requests to participate must be submitted electronically via the CTM e-procurement portal at https://uk.eu-supply.com If not already registered on CTM eu-supply.com you will need to register as a supplier to express interest. Lot 2: Aseptically prepared products Supply of Carboplatin, Epirubicin, Nivolumab & Paclitaxel. Lot 3: Aseptically Prepared Products Supply of Atezolizumab (Tecentriq®), Bortezomib Subcut, Docetaxel, Fluorouracil, Oxaliplatin & Vincristine. Lot 4a: Aseptically Prepared Products Supply of Cytarabine, Daunorubicin, Ganciclovir & Vinblastine. Lot 4b: Aseptically Prepared Products Supply of Cabazitaxel